Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP015K Following Single Oral Doses to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2016
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Psoriasis; Transplant rejection
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Nov 2016 Results of this and one other study published in the Clinical Pharmacology in Drug Development.
- 06 Jul 2011 New trial record